Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.

De Bari B, Franzetti-Pellanda A, Saidi A, Biggiogero M, Hahnloser D, Montemurro M, Bourhis J, Zeverino M, Ozsahin M.

J Cancer Res Clin Oncol. 2019 Apr;145(4):1075-1084. doi: 10.1007/s00432-019-02881-8. Epub 2019 Mar 4.

PMID:
30830296
2.

Response of locally advanced rectal cancer (LARC) to radiochemotherapy: DW-MRI and multiparametric PET/CT in correlation with histopathology.

Cerny M, Dunet V, Rebecchini C, Hahnloser D, Prior J, Sempoux C, Schmidt S.

Nuklearmedizin. 2019 Feb;58(1):28-38. doi: 10.1055/a-0809-4670. Epub 2019 Feb 15.

PMID:
30769371
3.

Shortcuts to intestinal carcinogenesis by genetic engineering in organoids.

Maru Y, Onuma K, Ochiai M, Imai T, Hippo Y.

Cancer Sci. 2019 Mar;110(3):858-866. doi: 10.1111/cas.13938. Epub 2019 Feb 3. Review.

4.

Novelties in treatment of locally advanced rectal cancer.

Grass F, Mathis K.

F1000Res. 2018 Nov 29;7. pii: F1000 Faculty Rev-1868. doi: 10.12688/f1000research.16194.1. eCollection 2018. Review.

5.

Long-term results of intersphincteric resection for low rectal cancer in Japan.

Yamada K, Saiki Y, Takano S, Iwamoto K, Tanaka M, Fukunaga M, Noguchi T, Nakamura Y, Hisano S, Fukami K, Kuwahara D, Tsuji Y, Takano M, Usuku K, Ikeda T, Sugihara K.

Surg Today. 2019 Apr;49(4):275-285. doi: 10.1007/s00595-018-1754-4. Epub 2019 Jan 2. Review. Erratum in: Surg Today. 2019 Feb 8;:.

PMID:
30604217
6.

Neoadjuvant chemoradiation and rectal cancer.

Chetty R, McCarthy AJ.

J Clin Pathol. 2019 Feb;72(2):97-101. doi: 10.1136/jclinpath-2018-205592. Epub 2018 Dec 28. Review.

PMID:
30593459
7.

The Toldt fascia: A historic review and surgical implications in complete mesocolic excision for colon cancer.

Liang JT, Huang J, Chen TC, Hung JS.

Asian J Surg. 2019 Jan;42(1):1-5. doi: 10.1016/j.asjsur.2018.11.006. Epub 2018 Dec 3. Review.

8.

A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.

Rades D, Vogelsang RP, Treder M, Janssen S, Schild SE, Holländer NH, Gögenur I.

Anticancer Res. 2018 Dec;38(12):6877-6880. doi: 10.21873/anticanres.13063.

PMID:
30504404
9.

Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.

Shao H, Ma X, Gao Y, Wang J, Wu J, Wang B, Li J, Tian J.

Medicine (Baltimore). 2018 Nov;97(48):e12900. doi: 10.1097/MD.0000000000012900. Review.

10.

Chemoprevention of Colorectal Cancer by Dietary Compounds.

Costea T, Hudiță A, Ciolac OA, Gălățeanu B, Ginghină O, Costache M, Ganea C, Mocanu MM.

Int J Mol Sci. 2018 Nov 28;19(12). pii: E3787. doi: 10.3390/ijms19123787. Review.

11.

Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).

Komori K, Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Shiomi A, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Kinugasa Y, Takii Y, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group.

Eur J Surg Oncol. 2019 Mar;45(3):336-340. doi: 10.1016/j.ejso.2018.11.016. Epub 2018 Nov 20.

PMID:
30477950
12.

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial.

Hu H, Huang J, Lan P, Wang L, Huang M, Wang J, Deng Y.

BMC Cancer. 2018 Nov 20;18(1):1145. doi: 10.1186/s12885-018-4997-y.

13.

One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?

Krajewska JB, Fichna J, Mosińska P.

Crit Rev Oncol Hematol. 2018 Dec;132:1-8. doi: 10.1016/j.critrevonc.2018.09.006. Epub 2018 Sep 15. Review.

PMID:
30447913
14.

Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Schurink NW, Lambregts DMJ, Beets-Tan RGH.

Br J Radiol. 2019 Apr;92(1096):20180655. doi: 10.1259/bjr.20180655. Epub 2019 Mar 5. Review.

PMID:
30433814
15.

Is "watch-and-wait" after chemoradiotherapy safe in patients with rectal cancer?

Smith FM, Cresswell K, Myint AS, Renehan AG.

BMJ. 2018 Nov 13;363:k4472. doi: 10.1136/bmj.k4472. Review. No abstract available.

PMID:
30425053
16.

Transluminal Cancer Surgery.

Lacy AM, Borja De Lacy F, Valverde S.

Surg Oncol Clin N Am. 2019 Jan;28(1):101-113. doi: 10.1016/j.soc.2018.08.003. Epub 2018 Oct 23. Review.

PMID:
30414675
17.

The value of magnetic resonance imaging to diagnose pathological complete response of rectal cancer after therapy: A protocol for meta-analysis.

Zhang M, Li J, Ma X, Wang B, Wu J, Gao Y, Tian J, Wang J.

Medicine (Baltimore). 2018 Oct;97(43):e12901. doi: 10.1097/MD.0000000000012901. Review.

18.
19.

A quest for sphincter-saving surgery in ultralow rectal tumours-a single-centre cohort study.

Rubinkiewicz M, Zarzycki P, Czerwińska A, Wysocki M, Gajewska N, Torbicz G, Budzyński A, Pędziwiatr M.

World J Surg Oncol. 2018 Nov 7;16(1):218. doi: 10.1186/s12957-018-1513-4.

20.

Low Anterior Resection Syndrome and Quality of Life After Sphincter-Sparing Rectal Cancer Surgery: A Long-term Longitudinal Follow-up.

Pieniowski EHA, Palmer GJ, Juul T, Lagergren P, Johar A, Emmertsen KJ, Nordenvall C, Abraham-Nordling M.

Dis Colon Rectum. 2019 Jan;62(1):14-20. doi: 10.1097/DCR.0000000000001228.

PMID:
30394987

Supplemental Content

Loading ...
Support Center